MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursdays Pre-Market Session
IMCR Stock | USD 29.02 0.08 0.27% |
Slightly above 54% of Immunocore Holdings' investor base is interested to short. The analysis of the overall investor sentiment regarding Immunocore Holdings suggests that many traders are impartial. Immunocore Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Immunocore Holdings. Many technical investors use Immunocore Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immunocore |
U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.
Read at benzinga.com
Immunocore Holdings Current Investor Sentiment
Panic Vs Confidence
46
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Immunocore Holdings' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Immunocore Holdings.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
Immunocore Holdings Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Immunocore Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Immunocore Holdings Historical Investor Sentiment
Investor biases related to Immunocore Holdings' public news can be used to forecast risks associated with an investment in Immunocore. The trend in average sentiment can be used to explain how an investor holding Immunocore can time the market purely based on public headlines and social activities around Immunocore Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunocore Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunocore Holdings and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Immunocore Holdings news discussions. The higher the estimate score, the more favorable the investor's outlook on Immunocore Holdings.
Immunocore Holdings Maximum Pain Price Across April 17th 2025 Option Contracts
Immunocore Holdings' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Immunocore Holdings close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Immunocore Holdings' options.
Immunocore Holdings Fundamental Analysis
We analyze Immunocore Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunocore Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunocore Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Immunocore Holdings is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Immunocore Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunocore Holdings stock to make a market-neutral strategy. Peer analysis of Immunocore Holdings could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics with similar companies.
Peers
Immunocore Holdings Related Equities
VTYX | Ventyx Biosciences | 6.88 | ||||
DSGN | Design Therapeutics | 6.75 | ||||
VRDN | Viridian Therapeutics | 6.27 | ||||
LRMR | Larimar Therapeutics | 3.29 | ||||
MIRM | Mirum Pharmaceuticals | 2.44 | ||||
KALV | Kalvista Pharmaceuticals | 0.61 | ||||
NUVL | Nuvalent | 0.20 | ||||
ERAS | Erasca | 0.54 | ||||
ACLX | Arcellx | 0.79 | ||||
GLUE | Monte Rosa | 1.74 | ||||
PCVX | Vaxcyte | 2.88 | ||||
LYRA | Lyra Therapeutics | 5.00 |
Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.